PHASTAR celebrates opening of new Boston office!
PHASTAR's Boston office has officially opened! The opening represents an important milestone in PHASTAR's history as its second office in the US and its first in the important Life Science Corridor of Massachusetts.
Commenting on the new Boston location, PHASTAR’s CEO Kevin Kane stated: “this is a huge step forward for PHASTAR and it demonstrates our determination to grow significantly over the next five years. We are delighted to be amongst the 1,000+ biotech and pharma companies which make up Boston’s Life Science hub”.
PHASTAR's newly appointed Director of Biostatistics, Paul Stark, will head up the Boston site. Paul brings with him over 20 years of clinical trials experience and has served as a director for more than 13 years at CROs and in medical centers and academic settings. Paul has applied statistics to medical devices and drugs for cardiology, nephrology, oral health, environmental health and oncology and has also authored and co-authored more than 65 manuscripts in peer-reviewed journals.